Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals.

Bar-On Y, Gruell H, Schoofs T, Pai JA, Nogueira L, Butler AL, Millard K, Lehmann C, Suárez I, Oliveira TY, Karagounis T, Cohen YZ, Wyen C, Scholten S, Handl L, Belblidia S, Dizon JP, Vehreschild JJ, Witmer-Pack M, Shimeliovich I, Jain K, Fiddike K, Seaton KE, Yates NL, Horowitz J, Gulick RM, Pfeifer N, Tomaras GD, Seaman MS, Fätkenheuer G, Caskey M, Klein F, Nussenzweig MC.

Nat Med. 2018 Sep 26. doi: 10.1038/s41591-018-0186-4. [Epub ahead of print]

PMID:
30258217
2.

The biomass distribution on Earth.

Bar-On YM, Phillips R, Milo R.

Proc Natl Acad Sci U S A. 2018 Jun 19;115(25):6506-6511. doi: 10.1073/pnas.1711842115. Epub 2018 May 21.

3.

Physical Training in a Medical Fitness Room for Patients with Chronic Diseases: Functional and Metabolic Outcomes.

Tayer-Shifman OE, Bar-On Y, Pereg D, Hershko AY.

Isr Med Assoc J. 2018 Jan;20(1):20-24.

4.

The genetic basis for the adaptation of E. coli to sugar synthesis from CO2.

Herz E, Antonovsky N, Bar-On Y, Davidi D, Gleizer S, Prywes N, Noda-Garcia L, Lyn Frisch K, Zohar Y, Wernick DG, Savidor A, Barenholz U, Milo R.

Nat Commun. 2017 Nov 22;8(1):1705. doi: 10.1038/s41467-017-01835-3.

5.

Adherence and Persistence with Drug Therapy among Fibromyalgia Patients: Data from a Large Health Maintenance Organization.

Ben-Ami Shor D, Weitzman D, Dahan S, Gendelman O, Bar-On Y, Amital D, Shalev V, Chodick G, Amital H.

J Rheumatol. 2017 Oct;44(10):1499-1506. doi: 10.3899/jrheum.170098. Epub 2017 Aug 1. Erratum in: J Rheumatol. 2017 Nov;44(11):1762.

PMID:
28765248
6.

Non-neutralizing Antibodies Alter the Course of HIV-1 Infection In Vivo.

Horwitz JA, Bar-On Y, Lu CL, Fera D, Lockhart AAK, Lorenzi JCC, Nogueira L, Golijanin J, Scheid JF, Seaman MS, Gazumyan A, Zolla-Pazner S, Nussenzweig MC.

Cell. 2017 Aug 10;170(4):637-648.e10. doi: 10.1016/j.cell.2017.06.048. Epub 2017 Jul 27.

7.

NKp46 Recognizes the Sigma1 Protein of Reovirus: Implications for Reovirus-Based Cancer Therapy.

Bar-On Y, Charpak-Amikam Y, Glasner A, Isaacson B, Duev-Cohen A, Tsukerman P, Varvak A, Mandelboim M, Mandelboim O.

J Virol. 2017 Sep 12;91(19). pii: e01045-17. doi: 10.1128/JVI.01045-17. Print 2017 Oct 1.

8.

Vigilin Regulates the Expression of the Stress-Induced Ligand MICB by Interacting with Its 5' Untranslated Region.

Berhani O, Nachmani D, Yamin R, Schmiedel D, Bar-On Y, Mandelboim O.

J Immunol. 2017 May 1;198(9):3662-3670. doi: 10.4049/jimmunol.1601589. Epub 2017 Mar 29.

9.

NK-cell receptors NKp46 and NCR1 control human metapneumovirus infection.

Diab M, Glasner A, Isaacson B, Bar-On Y, Drori Y, Yamin R, Duev-Cohen A, Danziger O, Zamostiano R, Mandelboim M, Jonjic S, Bacharach E, Mandelboim O.

Eur J Immunol. 2017 Apr;47(4):692-703. doi: 10.1002/eji.201646756. Epub 2017 Mar 6.

10.

Design principles of autocatalytic cycles constrain enzyme kinetics and force low substrate saturation at flux branch points.

Barenholz U, Davidi D, Reznik E, Bar-On Y, Antonovsky N, Noor E, Milo R.

Elife. 2017 Feb 7;6. pii: e20667. doi: 10.7554/eLife.20667.

11.

Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controller.

Freund NT, Wang H, Scharf L, Nogueira L, Horwitz JA, Bar-On Y, Golijanin J, Sievers SA, Sok D, Cai H, Cesar Lorenzi JC, Halper-Stromberg A, Toth I, Piechocka-Trocha A, Gristick HB, van Gils MJ, Sanders RW, Wang LX, Seaman MS, Burton DR, Gazumyan A, Walker BD, West AP Jr, Bjorkman PJ, Nussenzweig MC.

Sci Transl Med. 2017 Jan 18;9(373). pii: eaal2144. doi: 10.1126/scitranslmed.aal2144.

12.

Sugar Synthesis from CO2 in Escherichia coli.

Antonovsky N, Gleizer S, Noor E, Zohar Y, Herz E, Barenholz U, Zelcbuch L, Amram S, Wides A, Tepper N, Davidi D, Bar-On Y, Bareia T, Wernick DG, Shani I, Malitsky S, Jona G, Bar-Even A, Milo R.

Cell. 2016 Jun 30;166(1):115-25. doi: 10.1016/j.cell.2016.05.064. Epub 2016 Jun 23.

13.

HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption.

Scheid JF, Horwitz JA, Bar-On Y, Kreider EF, Lu CL, Lorenzi JC, Feldmann A, Braunschweig M, Nogueira L, Oliveira T, Shimeliovich I, Patel R, Burke L, Cohen YZ, Hadrigan S, Settler A, Witmer-Pack M, West AP Jr, Juelg B, Keler T, Hawthorne T, Zingman B, Gulick RM, Pfeifer N, Learn GH, Seaman MS, Bjorkman PJ, Klein F, Schlesinger SJ, Walker BD, Hahn BH, Nussenzweig MC, Caskey M.

Nature. 2016 Jul 28;535(7613):556-60. Epub 2016 Jun 22.

14.

CEACAM1-Mediated Inhibition of Virus Production.

Vitenshtein A, Weisblum Y, Hauka S, Halenius A, Oiknine-Djian E, Tsukerman P, Bauman Y, Bar-On Y, Stern-Ginossar N, Enk J, Ortenberg R, Tai J, Markel G, Blumberg RS, Hengel H, Jonjic S, Wolf DG, Adler H, Kammerer R, Mandelboim O.

Cell Rep. 2016 Jun 14;15(11):2331-9. doi: 10.1016/j.celrep.2016.05.036. Epub 2016 Jun 2.

15.

SnapShot: Timescales in Cell Biology.

Shamir M, Bar-On Y, Phillips R, Milo R.

Cell. 2016 Mar 10;164(6):1302-1302.e1. doi: 10.1016/j.cell.2016.02.058. No abstract available.

16.

The human 2B4 and NTB-A receptors bind the influenza viral hemagglutinin and co-stimulate NK cell cytotoxicity.

Duev-Cohen A, Bar-On Y, Glasner A, Berhani O, Ophir Y, Levi-Schaffer F, Mandelboim M, Mandelboim O.

Oncotarget. 2016 Mar 15;7(11):13093-105. doi: 10.18632/oncotarget.7597.

17.

Cytokine secretion and NK cell activity in human ADAM17 deficiency.

Tsukerman P, Eisenstein EM, Chavkin M, Schmiedel D, Wong E, Werner M, Yaacov B, Averbuch D, Molho-Pessach V, Stepensky P, Kaynan N, Bar-On Y, Seidel E, Yamin R, Sagi I, Elpeleg O, Mandelboim O.

Oncotarget. 2015 Dec 29;6(42):44151-60. doi: 10.18632/oncotarget.6629.

18.

Dynamic Co-evolution of Host and Pathogen: HCMV Downregulates the Prevalent Allele MICA∗008 to Escape Elimination by NK Cells.

Seidel E, Le VT, Bar-On Y, Tsukerman P, Enk J, Yamin R, Stein N, Schmiedel D, Oiknine Djian E, Weisblum Y, Tirosh B, Stastny P, Wolf DG, Hengel H, Mandelboim O.

Cell Rep. 2015 Feb 12. pii: S2211-1247(15)00054-6. doi: 10.1016/j.celrep.2015.01.029. [Epub ahead of print]

19.

Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack.

Gur C, Ibrahim Y, Isaacson B, Yamin R, Abed J, Gamliel M, Enk J, Bar-On Y, Stanietsky-Kaynan N, Coppenhagen-Glazer S, Shussman N, Almogy G, Cuapio A, Hofer E, Mevorach D, Tabib A, Ortenberg R, Markel G, Miklić K, Jonjic S, Brennan CA, Garrett WS, Bachrach G, Mandelboim O.

Immunity. 2015 Feb 17;42(2):344-355. doi: 10.1016/j.immuni.2015.01.010. Epub 2015 Feb 10.

20.

Identification of putative novel O-glycosylations in the NK killer receptor Ncr1 essential for its activity.

Glasner A, Roth Z, Varvak A, Miletic A, Isaacson B, Bar-On Y, Jonjic S, Khalaila I, Mandelboim O.

Cell Discov. 2015 Dec 22;1:15036. doi: 10.1038/celldisc.2015.36. eCollection 2015.

21.

Genome-wide SNP-genotyping array to study the evolution of the human pathogen Vibrio vulnificus biotype 3.

Raz N, Danin-Poleg Y, Hayman RB, Bar-On Y, Linetsky A, Shmoish M, Sanjuán E, Amaro C, Walt DR, Kashi Y.

PLoS One. 2014 Dec 19;9(12):e114576. doi: 10.1371/journal.pone.0114576. eCollection 2014.

22.

Old obstacles but new hopes: trying to understand the fibromyalgia construct.

Bar-On Y, Shalev V, Weitzman D, Chodick G, Amital H.

Isr Med Assoc J. 2014 Oct;16(10):625-6. No abstract available.

23.

[Sexual behavior characteristics of clients attending the Israel AIDS Task Force anonymous clinic in Tel Aviv].

Bar-On Y, Perry ZH, Nof E, Shiber A, Risenberg K, Ben Zion I.

Harefuah. 2014 Sep;153(9):506-10, 560. Hebrew.

PMID:
25417483
24.

Influenza virus uses its neuraminidase protein to evade the recognition of two activating NK cell receptors.

Bar-On Y, Seidel E, Tsukerman P, Mandelboim M, Mandelboim O.

J Infect Dis. 2014 Aug 1;210(3):410-8. doi: 10.1093/infdis/jiu094. Epub 2014 Feb 14.

25.

Natural killer cell-mediated host defense against uropathogenic E. coli is counteracted by bacterial hemolysinA-dependent killing of NK cells.

Gur C, Coppenhagen-Glazer S, Rosenberg S, Yamin R, Enk J, Glasner A, Bar-On Y, Fleissig O, Naor R, Abed J, Mevorach D, Granot Z, Bachrach G, Mandelboim O.

Cell Host Microbe. 2013 Dec 11;14(6):664-74. doi: 10.1016/j.chom.2013.11.004.

26.

It's not black or white-on the range of vision and echolocation in echolocating bats.

Boonman A, Bar-On Y, Cvikel N, Yovel Y.

Front Physiol. 2013 Sep 11;4:248. doi: 10.3389/fphys.2013.00248. eCollection 2013.

27.

The viral KSHV chemokine vMIP-II inhibits the migration of Naive and activated human NK cells by antagonizing two distinct chemokine receptors.

Yamin R, Kaynan NS, Glasner A, Vitenshtein A, Tsukerman P, Bauman Y, Ophir Y, Elias S, Bar-On Y, Gur C, Mandelboim O.

PLoS Pathog. 2013 Aug;9(8):e1003568. doi: 10.1371/journal.ppat.1003568. Epub 2013 Aug 15.

28.

Neuraminidase-mediated, NKp46-dependent immune-evasion mechanism of influenza viruses.

Bar-On Y, Glasner A, Meningher T, Achdout H, Gur C, Lankry D, Vitenshtein A, Meyers AFA, Mandelboim M, Mandelboim O.

Cell Rep. 2013 Apr 25;3(4):1044-50. doi: 10.1016/j.celrep.2013.03.034. Epub 2013 Apr 18.

29.

Loss of kindlin-3 alters the threshold for NK cell activation in human leukocyte adhesion deficiency-III.

Gruda R, Brown AC, Grabovsky V, Mizrahi S, Gur C, Feigelson SW, Achdout H, Bar-On Y, Alon R, Aker M, Davis DM, Mandelboim O.

Blood. 2012 Nov 8;120(19):3915-24. doi: 10.1182/blood-2012-02-410795. Epub 2012 Sep 14.

30.

Elucidating the mechanisms of influenza virus recognition by Ncr1.

Glasner A, Zurunic A, Meningher T, Lenac Rovis T, Tsukerman P, Bar-On Y, Yamin R, Meyers AF, Mandeboim M, Jonjic S, Mandelboim O.

PLoS One. 2012;7(5):e36837. doi: 10.1371/journal.pone.0036837. Epub 2012 May 15.

31.

Killing of avian and Swine influenza virus by natural killer cells.

Achdout H, Meningher T, Hirsh S, Glasner A, Bar-On Y, Gur C, Porgador A, Mendelson M, Mandelboim M, Mandelboim O.

J Virol. 2010 Apr;84(8):3993-4001. doi: 10.1128/JVI.02289-09. Epub 2010 Feb 3.

32.

Coronary risk factor management in the framework of a community hospital-based ambulatory exercise training program.

Leibowitz M, Bental T, Neuman Y, Bar-On Y, Khaskia A, David D.

Prev Cardiol. 2004 Spring;7(2):59-63.

33.

Skin reactive hyperemia in diabetic patients. A study by laser Doppler flowmetry.

Tur E, Yosipovitch G, Bar-On Y.

Diabetes Care. 1991 Nov;14(11):958-62.

PMID:
1797508

Supplemental Content

Loading ...
Support Center